April 14, 2024

Pgiam/iStock through Getty Photographs

CARGO Therapeutics (NASDAQ:CRGX) IPO-ed in October with a plan to develop cell therapies for most cancers sufferers. Its pipeline is as follows:

Lead asset CRG-022, licensed from the Nationwide Most cancers Institute, is a CDD22